Service · 03 / 06

Growth, D2C Marketing & Referral Development

Centers do not fail because the technology underperforms. They fail because volume never shows up.

SEARCHSOCIALAISEOCOMMUNITYREFERRALSWORD OF MOUTHEMAIL

Ideal clients

  • Operating centers
  • New launches
  • Repositioning assets
  • Network strategies

Typical outcomes

  • A referral engine that produces measurable patient flow
  • Positioning that holds up against the local competitive set
  • A BD function with real accountability, not slogans

Proton centers don't fail because the technology underperforms. They fail because the patients, referrals, and market positioning never showed up. We focus on what actually moves volume, direct-to-consumer demand and a referral engine that produces measurable patient flow.

Filling a proton center is a different problem from filling a typical oncology service line. The referral physics, payer dynamics, and patient decision journey are specific, and most centers under-invest in the parts that matter most.

We build practical growth strategies grounded in how patients and referring physicians actually behave around proton therapy, not in generic healthcare marketing playbooks.

Sample scope

  • Direct-to-consumer (D2C) patient acquisition strategy
  • Referral development and physician engagement
  • Market activation and launch support
  • Positioning, narrative, and competitive differentiation
  • Sales and BD team structure and accountability
  • Digital, content, and paid media programs sized to the catchment
The market is moving

In a decade, D2C went from a line item to the front door.

US healthcare D2C spend has compounded across every digital channel since 2015, and the mix has shifted. Patients now discover, evaluate, and self-refer through search, social, content, and AI long before they meet a physician. The practices that own this funnel are quietly compounding patient volume against the ones that haven't built it yet.

A decade of digital

US healthcare D2C marketing spend, 2015–2024

Digital acquisition has moved from experimental line item to the dominant patient-growth channel. Hover any year to see the mix.

2024 spend
$24.2B
10-yr growth
7.3×
CAGR
24.8%
$0B$0B$6B$6B$13B$13B$19B$19B$25B$25B2015201620172018201920202021202220232024
Paid Search
Branded + condition-level intent capture (Google, Bing).
Display & Programmatic
Retargeting, condition audiences, OTT/CTV pre-roll.
Social
Meta, TikTok, YouTube, community + paid acquisition.
Content & SEO
Condition pages, physician content, organic discoverability.
CRM & Email
Patient nurture, recall campaigns, referral activation.
AI & Generative Search
LLM answer presence, AI chat assistants, AI-driven ad ops.
The shift

In 2015, paid search was nearly half of healthcare D2C. By 2024, social, content, and AI-native channels combined are the larger share, and they're still the fastest growing.

The breakout

AI & Generative Search is the fastest mover of the last five years, growing roughly 20.0× , most practices have not yet built a muscle here.

What it means

Patients now research, compare, and self-refer through digital channels long before a physician referral arrives. Practices that own this funnel compound volume; those that don't subsidize it for competitors.

Sources: composite of eMarketer, Definitive Healthcare, IAB, Klick Health, Pew (2015–2024).Illustrative · directional

Most engagements start with a single, focused conversation.

Tell us where the situation is, and we'll tell you whether we're the right firm for it.